STOCK TITAN

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (NASDAQ:OCS) announced the vesting and settlement of Restricted Stock Units (RSUs) for director Arshad Khanani. The RSUs were previously granted as part of the company's equity compensation program.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OCS

+4.89%
1 alert
+4.89% News Effect

On the day this news was published, OCS gained 4.89%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ZUG, Switzerland, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company.

Attachment


FAQ

What type of transaction was announced by Oculis (OCS) on September 3, 2025?

Oculis announced the vesting and settlement of previously granted Restricted Stock Units (RSUs) for director Arshad Khanani.

Who is Arshad Khanani at Oculis (OCS)?

Arshad Khanani is a director at Oculis who received RSUs as part of the company's equity compensation program.

What are RSUs in the context of Oculis stock?

RSUs (Restricted Stock Units) are a form of equity compensation that gives employees and directors the right to receive company stock after meeting vesting requirements.

When did the RSU transaction for Oculis director take place?

The RSU vesting and settlement was announced on September 3, 2025.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.66B
50.32M
Biotechnology
Healthcare
Link
Switzerland
Zug